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Background: Staphylococcus aureus (S. aureus), including MRSA, is considered to be the leading cause of
surgical site infection (SSI) after orthopedic surgery. We screened for nasal carriers of S. aureus among
patients who were scheduled to undergo orthopedic surgery at our hospital to reveal the effect of nasal
S. aureus carriage on SSI. Our study design clearly has the intent of ﬁnding S. aureus nasal carriage and
eradicating MRSA when found, and this strategy is to verify whether it's effective for preventing or-
thopedic surgical infections.
Methods: Subjects were 4148 patients who underwent preoperative screening for nasal carrier and
subsequently underwent orthopedic surgery during a 7-year period between April 2007 and March 2014.
The incidence of SSI among patients who were operated in our department was investigated, and the
rates were compared between patients with and without nasal carriage to reveal the effect of preop-
erative nasal carriage on SSI.
Results: In total, 1036 patients were nasal carriers of S. aureus (carriage rate, 25.0%), whereas 140 patients
carried MRSA (carriage rate, 3.4%). SSI developed in 24 patients [incidence, 0.58% (24/4148)] consisting of
12 non-carriers [0.39% (12/3112)] and 12 carriers [1.16% (12/1036)] with a signiﬁcant difference in the
incidence between the groups. Among 24 cases of SSI, more than half (13 cases) were caused by bacterial
species other than S. aureus or those that could not be detected by the tests used. Only 7 patients out of
24 SSI patients, S. aureus was the bacterium detected in preoperative nasal cultures and the causal
bacterium for SSI (concordance rate of 29.2%).
Conclusions: It was difﬁcult to reduce the incidence rate of SSI in eradication group to the same level as
nasal culture negative group. However, nasal carriage of S. aureus or MRSA may be a risk factor for SSI in
orthopedic surgery.
© 2017 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.1. Introduction
Staphylococcus aureus (S. aureus), including methicillin-resistant
S. aureus (MRSA), may be the leading cause of surgical site infection
(SSI) after orthopedic surgery. Causal bacteria for SSI are divided
into two groups based on their origins: exogenous agents, such as
intraoperative airborne bacteria, and endogenous agents, such as
bacteria carried by patients themselves. While exogenous originsNakamura).
tion. Published by Elsevier B.V. Allhave always been considered important, recent studies focus more
attention to endogenous infection caused by bacteria originating in
patients. However, it is currently unclear whether nasal bacterial
carriage is an endogenous risk factor for SSI.2. Objectives
To reveal the effect of nasal S. aureus carriage on SSI, we
screened for nasal carriers of S. aureus (including MRSA) among
patients who were scheduled to undergo orthopedic surgery at our
hospital. Our study design clearly has the intent of ﬁnding S. aureus
nasal carriage and eradicating MRSAwhen found, and this strategyrights reserved.
Table 2
The rate of conducting post-MUP nasal culture and MRSA eradication by MUP.
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infections.Year Post-MUP nasal culture MRSA eradication
by MUP
2007e2010 39.1% (27/69) 77.8% (21/27)
2011e2014 49.3% (35/71) 74.3% (26/35)
Total 44.3% (62/140) 75.8% (47/62)
It was divided into a ﬁrst half and a second half.3. Subjects and methods
We calculated the annual rates of nasal S. aureus and MRSA
carriage in 4148 patients who had undergone outpatient preoper-
ative screening for nasal bacterial carriage prior to hospital
admission for orthopedic surgery during a 7-year period between
April 2007 and March 2014.
At our hospital, patients with nasal carriage of MRSA are treated
with topical “mupirocin (MUP)” three times a day for three days to
eradicate MRSA before surgery. In addition, preoperative prophy-
lactic administration of vancomycin is performed. Therefore, in this
study, the proportion of patients subjected to nasal cultures after
eradication and the proportion of those who had successful MRSA
eradication were determined to reveal the efﬁcacy of MUP. In
addition, we investigated background diseases in patients with
preoperative carriage of MRSA.
We then compared the incidence rates of SSI between patients
with andwithout nasal carriage during the corresponding period to
reveal whether preoperative nasal bacterial carriage affects SSI. A
diagnosis of SSI was made in accordance with the deﬁnition used in
the Guideline for Prevention of Surgical Site Infection published by
the United States Centers for Disease Control and Prevention (CDC)
[1].
This article has got institutional review board (IRB) approval for
all the investigation of human subjects in our institution.4. Results
In total, 1036 (25.0%) patients carried nasal S. aureus, whereas
140 (3.4%) were carrier of MRSA.
The annual incidence of nasal S. aureuswas 22.9% in 2007, 23.2%
in 2008, 26.2% in 2009, 27.5% in 2010, 25.2% in 2011, 25.4% in 2012,
and 23.7% in 2013, with a mean rate of 25.0%, while the incidence of
nasal MRSA in the same period was 2.4%, 2.3%, 5.9%, 3.1%, 2.7%, 3.5%,
and 3.4%, respectively, with a mean rate of 3.4% (Table 1).
The rate of conducting post-MUP nasal cultures was 44.3% (62/
140), and the rate of MRSA eradication by MUP was 75.8% (47/62)
(Table 2). Primary diseases/surgeries in the 140 patients positive for
MRSA culture were 38 (27.1%) spine surgeries, including 17 (12.1%)
spinal fusions with implants; 62 (44.3%) joint replacement sur-
geries including revision surgeries, consisting of 25 (17.9%) total hip
arthroplasty (THA) and 37 (26.4%) total knee arthroplasty (TKA);
and 40 (28.6%) other surgeries such as femoral head replacement
and osteosynthesis.
The CDC deﬁnes SSI as infection occurring within 30 days of any
operative procedure or occurring within one year after surgery
with implants. Based on this deﬁnition, 24 (incident rate of 0.58%)
patients (ten female and fourteen male, mean age at surgery 67.3
years (range, 39e88 years)) had SSI in this study after 19 spineTable 1
By year nasal culture colonization rate.
Year S. aureus MRSA
2007 22.9% (75/327) 2.4% (8/327)
2008 23.2% (122/526) 2.3% (12/526)
2009 26.2% (141/539) 5.9% (32/539)
2010 27.5% (160/581) 3.1% (18/581)
2011 25.2% (168/666) 2.7% (18/666)
2012 25.4% (188/740) 3.5% (26/740)
2013 23.7% (182/769) 3.4% (26/769)
Total 25.0% (1036/4148) 3.4% (140/4148)surgeries, consisting of 13 spinal fusions with implants; 4 joint
replacement surgeries, consisting of one each of THA, TKA, revision
THA, and revision TKA; and one invasive osteosynthesis. 24 cases of
SSI include 10 female and 14 male. The average age at the time of
surgery was 67.3 (39e88) years (Table 3). In addition, causal agents
were MRSA in 3 patients,methicillin-sensitive S. aureus (MSSA) in 8,
Staphylococcus epidermidis in 6, Streptococcus in 2, Enterococcus
faecalis in 2, coagulase-negative Staphylococcus (CNS) in 1, Escher-
ichia coli in 1, Bacteroides fragilis in 1, and no bacterium detected in
4. Multiple bacteria were detected in 2 patients. Among 24 cases of
SSI, more than half (13 cases) were caused by bacterial species other
than S. aureus or those that could not be detected by the tests used
(Table 4). After dividing 24 patients with SSI into those with
(n ¼ 12) or without (n ¼ 12) nasal carriage, the incidence of SSI
were analyzed using the Chi-square test, with the signiﬁcance set at
P < 0.01. The results showed that the rate was 1.16% (12/1036) and
0.39% (12/3112) in patients with and without nasal carriage,
respectively, with a signiﬁcantly high incidence of SSI in patients
carrying bacteria (Fig. 1).
Onset of SSI was a postoperative average of 2.1 months (range,
0.5e12months). In 7 patients, S. aureuswas the bacterium detected
in preoperative nasal cultures and the causal bacterium for SSI
(concordance rate of 29.2%) (Table 5). However, in this study, we did
not elucidate whether SSI was caused by endogenous factors, that
is, nasal S. aureus, in these patients.5. Discussion
Once patients develop SSI after orthopedic surgeries, especially
those with implants such as joint replacement surgery and spinal
fusion, it is often necessary to remove the implants, aggravating
their dysfunction. Matsushita et al. [2] emphasized the importance
of preventing SSI in bone and joints because of the difﬁculty
treating this type of infection even today with technological ad-
vances in the ﬁeld of antibiotics.
Against this background, the Japanese Orthopaedic Association
developed Japanese Orthopaedic Association (JOA) Clinical Practice
Guideline on the Prevention of Surgical Site Infections in Bone and
Joint [3]. To improve treatment outcome and patient prognosis, the
guideline recommends currently most appropriate preventive,
diagnostic, and treatment strategies for musculoskeletal disorders.
Also at our hospital, we developed the Guidelines for Healthcare
Hazard Control and Safety Management in April 2007 and have
subsequently established various preventive measures against
infection, including the Infection Control Committee and a SSI
surveillance system. Around the same time, our orthopedic surgery
department started routine preoperative screening for nasal bac-
terial carriage as a part of the surveillance system.
When MRSA is detected in preoperative nasal cultures at our
hospital, we perform the intranasal application of topical MUP
three times a day and chlorhexidine wipes at surgical sites once a
day for three days before surgery to eradicate MRSA. In addition,
vancomycin is administered intra-operatively as a preventive
measure. It is ideal to perform the whole-body washing of patients
Table 3
Primary disease and operative procedure of SSI 24 cases.
Case Age at
surgery
Gender Primary disease Operative procedure
1 77 F Old vertebral compression fractures Thoracolumbar spinal fusion
2 60 F Destructive spondyloarthropathy Lumbar spinal fusion
3 60 F Rheumatoid arthritis (RA) TKA
4 59 M Lumbar spinal canal stenosis Lumbar laminectomy
5 78 F Degenerative lumbar stenosis Lumbar spinal fusion
6 49 M Avascular necrosis of the femoral head THA
7 66 M Old vertebral compression fractures Thoracolumbar spinal fusion
8 39 M Lumbar disk herniation Lumbar disk herniotomy
9 85 M Osteoarthritis of the knee joint TKA revision
10 62 M Lumbar spinal canal stenosis Lumbar laminectomy
11 75 F Degenerative lumbar scoliosis Lumbar spinal fusion
12 48 F Degenerative spondylolisthesis Lumbar spinal fusion
13 67 M Lumbar spinal canal stenosis Lumbar laminectomy
14 88 F Degenerative spondylolisthesis Lumbar spinal fusion
15 56 M Destructive spondyloarthropathy Lumbar spinal fusion
16 58 M Lumbar spinal canal stenosis Lumbar spinal fusion
17 81 F Old vertebral compression fractures Thoracolumbar spinal fusion
18 77 M Cervical spondylotic myelopathy Cervical laminoplasty
19 82 M Lumbar spinal canal stenosis Lumbar spinal fusion
20 64 M Lumbar disk herniation Lumbar disk herniotomy
21 63 F Degenerative spondylolisthesis Lumbar spinal fusion
22 72 M Degenerative spondylolisthesis Lumbar spinal fusion
23 80 M Osteoarthritis of the hip joint THA revision
24 70 F Calcaneous fracture Osteosynthesis
Average 67.3 (39e88) F 10, M 14
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with chlorhexidine because of various issues such as equipment.
Regarding the timing of the eradication of nasal MRSA after
screening, we think it is best to initiate eradication 1 week before
surgery. At our hospital, patients are admitted 2 days before their
surgery. Therefore, to prevent nosocomial spread to other in-
patients, MRSA carriers who are scheduled to undergo surgery
should complete the eradication ofMRSA by the day before hospital
admission. Another reason to complete the eradication of MRSA
immediately prior to surgery, if possible, is the uncertainty about
how long the effect of eradication lasts. Although we did not
investigate the recurrence rate of nasal MRSA carriage among the
present patients, we previously examined nasal screening of MRSA
carriers multiple times before they underwent elective surgeries
for different diseases at different times, and found that even after
eradication, patients who were once a carrier were more likely to
become infected again. We think this issue needs to be investigated
further.
The present ﬁndings showed that patients with nasal carriage of
S. aureus had a higher incidence of SSI than those without. We
hypothesize that in patients who carry nasal S. aureus and have
poor health such as a weakened immune system, surgery requiring
general anesthesia via intratracheal intubation may induce the
intraoperative or postoperative transmission of the bacteria to the
trachea and lungs, causing adverse events. In other words, it isTable 4
Causal bacteria of SSI.
Detected bacteria (SSI 24 cases) Cases
MRSA 3
Methicillin-sensitive S. aureus 8
S. epidermidis 6
Streptococcus 2
Enterococcus 2
Coagulase negative Staphylococcus 1
Escherichia coli 1
Bacteroides fragilis 1
Not detected 4possible that relatively harmless resident bacteria turn into
opportunistic pathogens because of the declining clinical status of
the patient, causing systemic infection and thus SSI [6,14,15,17,18].
Therefore, nasal S. aureus eradication is important in terms of
avoiding this kind of situation, too.
There have been several reports on the importance of pre-
operative eradication. The Society for Healthcare Epidemiology of
America (SHEA) promotes active eradication programs in carriers of
MRSA [9]. Using real-time polymerase chain reaction, Bode et al. [4]
screened patients for nasal S. aureus carriage immediately after
hospital admission and performed the intranasal application of
topical MUP and the whole-body washing with chlorhexidine.
These measures reduced the occurrence of SSI signiﬁcantly,
showing the importance of eradicating the bacterium from not only
the nasal cavities, but also the entire body surface. Saitoh et al. [5]
also reported recently that preoperative screening and intranasal
and whole-body eradication in patients carrying bacteria could
reduce the incidence of perioperative SSI.
Furthermore, Tsujihara et al. [6] have shown the importance of
post-eradication cultures for identifying the improper use or
tolerance of MUP. However, caution must be paid when applying
MUP for a long time or on body areas other than nasal cavities
because of its association with MUP resistant strains as shown in
some studies [7,8].
In the present study, the rate of conducting post-MUP nasal
cultures was as low as 44.3%. However, after mandating the culture
in April 2014, the rate has increased to 78.6% by June 2015. In
addition, the 75.8% eradication rate suggests that MUP successfully
eradicates MRSA in three out of four patients.
In this study, we did not thoroughly investigate whether host
factors varied between patients with and without MRSA, but the
proportion of MRSA carriers tended to increase in health care
workers and individuals who had recently been admitted to a
hospital or care facility.
From time to time, studies in the ﬁeld of orthopedic surgery
have shown the involvement of nasal carriage of S. aureus including
MRSA in SSI [10e13]. The association between nasal MRSA carriage
and infection in other body areas has also been shown occasionally
Fig. 1. Flow chart shows a comparison of surgical site infection (SSI) between patients with and without nasal carriage (using the Chi-square test, with the signiﬁcance set at
P < 0.01).
M. Nakamura et al. / Journal of Orthopaedic Science 22 (2017) 778e782 781[14,15]. However, other studies reported the no association be-
tween preoperative bacterial carriage and SSI [16].
In this study, the antibiotic agent mupirocin achieved eradica-
tion in 75.8%, but not all, of MRSA cases. The living environment
might have been the factor differentiating successful cases from
unsuccessful ones. Because of exposure to the outside world, the
nasal cavity easily comes in contact with various bacterial species.
When MRSA is present in the environment, patients may easily
become a carrier even after eradication. However, the eradication
rate of 75.8% in this study suggests that eradication was successfulTable 5
The relationship between preoperative nasal carriage and perioperative infection bacter
Case Age at surgery Gender Onset of SSI
(months)
Nasal cult
before sur
1 77 F 3 negative
2 60 F 1.2 MSSA
3 60 F 8.1 MSSA
4 59 M 1.5 negative
5 78 F 1.2 MSSA
6 49 M 4.9 MSSA
7 66 M 0.9 MSSA
8 39 M 1.1 MSSA
9 85 M 2 negative
10 62 M 1 negative
11 75 F 1 MRSA
12 48 F 12 negative
13 67 M 1.5 MSSA
14 88 F 1 negative
15 56 M 1 MRSA
16 58 M 0.5 MSSA
17 81 F 1 negative
18 77 M 0.5 negative
19 82 M 1 MRSA
20 64 M 1 negative
21 63 F 1 negative
22 72 M 1 negative
23 80 M 1.5 negative
24 70 F 1 MSSA
Mean 67.3 2.1in 3 out of 4 patients, emphasizing the signiﬁcance of the
procedure.
In a previous study by another group, the occurrence of SSI
could not be prevented completely even after successful preoper-
ative eradication [10]. In our study as well, it was not possible to
eradicateMRSA completely. This suggests that the occurrence of SSI
is not simple because of the involvement of many factors, besides
bacterial carriage, as described in the Japanese Orthopaedic Asso-
ciation (JOA) Clinical Practice Guideline on the Prevention of Sur-
gical Site Infections in Bone and joint [3].ia of SSI 24 cases.
ure
gery
Infection-causing bacteria Concordance of
the bacteria
S. epidermidis
MSSA C
Streptococcus
MRSA
S. epidermidis
MSSA C
S. epidermidis
MSSA C
negative
MSSA
MRSA C
Streptococcus
MSSA C
MSSA
negative
MSSA, S. epidermidis C
E. coli, E. faecalis, B. fragilis
negative
MRSA C
MSSA
negative
E. faecalis
CNS, S. epidermidis
S. epidermidis
Concordance rate 29.2% (7/24)
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(13 cases) were caused by bacterial species other than S. aureus or
those that could not be detected by the tests used (Tables 4 and 5).
What is more, only 7 patients out of 24 SSI patients, S. aureus was
the bacterium detected in preoperative nasal cultures and the
causal bacterium for SSI (concordance rate of 29.2%) (Table 5). This
study compared incidence rate of SSI between nasal culture posi-
tive group and nasal culture negative group. This study did not
compare between group with eradication and group without
eradication. Therefore, it is difﬁcult to judge efﬁcacy of eradication
of bacteria. One proven thing in this study was that it was difﬁcult
to reduce the incidence rate of SSI in eradication group to the same
level as nasal culture negative group.
On the other hand, preoperative MUP treatment was fairly
effective, achieving an approximately 75% eradication rate
(Table 2), and the incidence of SSI was signiﬁcantly higher in pa-
tients with nasal carriage of S. aureus than in those without (Fig. 1),
indicating that preoperative screening and eradication measures
could have prevented SSI at least in some patients.
The limitation of this study is that no genetic analysis of nasal
S. aureus was conducted to elucidate whether the causal bacteria
for SSI had originated exogenously or endogenously.
6. Conclusion
Our conclusion from this study, which is a very extensive and
rigorous investigation, is that it is difﬁcult to reduce the incidence
rate of SSI in eradication group to the same level as nasal culture
negative group.
Because of the involvement of various risk factors, it is difﬁcult
to explain the occurrence of SSI just by comparing patients with
and without bacterial carriage. However, the ﬁndings of this study
suggest that nasal carriage of regular S. aureus or MRSA may be a
risk factor for SSI in orthopedic surgery.
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